VOLPI, Nicola
 Distribuzione geografica
Continente #
NA - Nord America 39.081
AS - Asia 20.614
EU - Europa 20.142
SA - Sud America 2.613
AF - Africa 438
OC - Oceania 102
Continente sconosciuto - Info sul continente non disponibili 35
Totale 83.025
Nazione #
US - Stati Uniti d'America 38.445
SG - Singapore 6.439
GB - Regno Unito 6.222
CN - Cina 5.504
IT - Italia 3.831
SE - Svezia 3.375
HK - Hong Kong 2.376
BR - Brasile 1.949
VN - Vietnam 1.857
DE - Germania 1.309
FI - Finlandia 1.098
UA - Ucraina 1.013
TR - Turchia 889
FR - Francia 874
KR - Corea 874
RU - Federazione Russa 685
BD - Bangladesh 662
IN - India 445
BG - Bulgaria 403
CA - Canada 307
ID - Indonesia 273
AR - Argentina 219
JP - Giappone 218
MX - Messico 217
NL - Olanda 217
PL - Polonia 161
ES - Italia 154
IQ - Iraq 137
PK - Pakistan 127
ZA - Sudafrica 109
CH - Svizzera 104
IE - Irlanda 104
CL - Cile 95
AE - Emirati Arabi Uniti 90
CO - Colombia 83
AU - Australia 80
TH - Thailandia 80
MY - Malesia 79
EC - Ecuador 72
IR - Iran 68
VE - Venezuela 67
BE - Belgio 64
MA - Marocco 61
PE - Perù 59
LT - Lituania 57
AT - Austria 55
EG - Egitto 55
GR - Grecia 54
UZ - Uzbekistan 54
PH - Filippine 52
DZ - Algeria 51
SA - Arabia Saudita 49
TN - Tunisia 47
RO - Romania 46
CZ - Repubblica Ceca 42
TW - Taiwan 40
SK - Slovacchia (Repubblica Slovacca) 39
KE - Kenya 37
PT - Portogallo 37
RS - Serbia 37
IL - Israele 36
NP - Nepal 35
JO - Giordania 34
DK - Danimarca 32
EU - Europa 25
PY - Paraguay 25
KZ - Kazakistan 23
QA - Qatar 23
BO - Bolivia 22
AZ - Azerbaigian 21
CR - Costa Rica 21
HU - Ungheria 21
NZ - Nuova Zelanda 21
UY - Uruguay 20
LB - Libano 17
AL - Albania 15
BH - Bahrain 15
HR - Croazia 15
JM - Giamaica 15
NG - Nigeria 15
SI - Slovenia 15
NO - Norvegia 14
OM - Oman 14
BY - Bielorussia 13
DO - Repubblica Dominicana 12
ET - Etiopia 12
PR - Porto Rico 12
HN - Honduras 11
SY - Repubblica araba siriana 11
MD - Moldavia 10
PS - Palestinian Territory 10
GE - Georgia 9
KG - Kirghizistan 9
TT - Trinidad e Tobago 9
AM - Armenia 8
AO - Angola 8
PA - Panama 8
CI - Costa d'Avorio 7
KW - Kuwait 7
MK - Macedonia 7
Totale 82.904
Città #
Singapore 4.471
Southend 4.419
Ashburn 3.581
Santa Clara 3.518
Fairfield 3.403
Woodbridge 2.606
Hong Kong 2.317
Chandler 2.101
Houston 2.074
Jacksonville 2.005
Hefei 1.884
Stockholm 1.809
Dearborn 1.557
Seattle 1.226
Wilmington 1.221
San Jose 1.197
Ann Arbor 1.189
Beijing 1.154
Cambridge 1.102
London 958
Nyköping 950
Helsinki 722
Council Bluffs 716
Seoul 649
Los Angeles 586
The Dalles 582
Ho Chi Minh City 574
New York 494
Hanoi 470
Modena 451
Princeton 414
Milan 407
Chicago 396
Sofia 380
Izmir 370
Eugene 356
San Diego 338
Buffalo 312
Lauterbourg 308
Redwood City 220
Moscow 215
Rome 180
Jakarta 169
Shanghai 161
Salt Lake City 153
São Paulo 153
Columbus 149
Dallas 138
Tokyo 131
Des Moines 127
Orem 108
Naples 101
Frankfurt am Main 99
Toronto 95
Falkenstein 94
Bologna 92
Munich 92
Dublin 85
Amsterdam 84
Falls Church 84
Haiphong 81
Dong Ket 80
Mexico City 77
Da Nang 76
Tampa 76
Boardman 67
Guangzhou 66
Istanbul 66
Paris 66
Rio de Janeiro 66
Chennai 65
Elk Grove Village 63
Kent 63
Miano 63
Atlanta 62
Brooklyn 62
Phoenix 62
Norwalk 60
Warsaw 56
Lesquin 55
Nanjing 55
Turku 54
Belo Horizonte 53
Florence 53
San Francisco 53
Baghdad 51
Brussels 49
Madrid 49
Bangkok 48
Turin 47
Kunming 45
Nuremberg 44
Sterling 44
Jinan 43
Tashkent 43
Buenos Aires 41
Johannesburg 41
Leipzig 41
Manchester 41
Montreal 41
Totale 58.265
Nome #
Adenylate pool and energy charge in human lymphocytes and granulocytes irradiated at 632 nm (HeNe Laser) 1.959
BIOCHIMICA STRUTTURALE, FUNZIONALE E METABOLICA 1.232
ACTIVITY STUDIES OF CHARACTERIZED, STANDARDIZED AND HIGHLY PURIFIED PROPOLIS EXTRACT 703
Recent advances in analytical approaches for the standardization and quality of polyphenols of propolis 625
Two analytical approaches to the evaluation of chondroitin sulfate in european food supplements. 586
A 96-well assay for uronic acid carbazole reaction 552
Chemical Composition and Antioxidant Activity of Propolis Prepared in Different Forms and in Different Solvents Useful for Finished Products 503
MOLECULAR COMPOSITION OF ACTIVE CHIOS MASTIC GUM COMPOUNDS, TERPENES, FOR USE IN COSMETIC, NUTRACEUTICAL, MEDICAL DEVICES AND PHARMACEUTICAL APPLICATIONS. 489
Differences among Three Branded Formulations of Hyaluronic Acid: Data from Environmental Scanning Electron Microscope Profile, Rheology Behavior and Biological Activity 464
Shockwave lithotripsy and the protective role of inosine: Early and late evaluation in an experimental model 421
ZFP36 stabilizes RIP1 via degradation of XIAP and cIAP2 thereby promoting ripoptosome assembly 404
Structural characterization of the skin glycosaminoglycans in patients with pseudoxanthoma elasticum 388
Determination of molecular mass values of chondroitin sulfates by fluorophore-assisted carbohydrate electrophoresis (FACE) 362
Beta-amyloid fibrillation and/or hyperhomocysteinemia modify striatal patterns of hyaluronic acid and dermatan sulfate: possible role in the pathogenesis of Alzheimer's disease. 359
Comparison of CPC and CETAB extractive procedures for quantification and characterization of human urinary glycosaminoglycans 357
Anomalous structure of urinary glycosaminoglycans in patients with pseudoxanthoma elasticum 356
Chondroitin sulfate/dermatan sulfate from corb (Sciaena umbra) skin: Purification, structural analysis and anticoagulant effect 356
Capillary blotting of glycosaminoglycans on nitrocellulose membranes after agarose-gel electrophoresis separation 356
Chondroitin Sulfate and Glucosamine as Disease Modifying Anti- Osteoarthritis Dru gs (DMOADs). 350
Plasmatic and urinary glycosaminoglycans characterization in mucopolysaccharidosis II Patient treated with enzyme-replacement therapy with Idursulfase 349
Chondroitin sulfate. Structure, role and pharmacological activity. Nicola Volpi (Editor) 348
Purification and structural elucidation of chondroitin sulfate/dermatan sulfate from Atlantic bluefin tuna (Thunnus thynnus) skins and their anticoagulant and ACE inhibitory activities 348
12 year follow up of enzyme-replacement therapy in two siblings with attenuated mucopolysaccharidosis I: the important role of early treatment. 346
Analytical aspects of pharmaceutical grade chondroitin sulfates 338
Analytical Methods for Assessing Chondroitin Sulfate in Human Plasma. 337
Biological effects and potential mechanisms of action of Pistacia lentiscus Chios mastic extract in Caco-2 cell model 332
Analysis of flavonoids from propolis by on-line HPLC-electrospray mass spectrometry 331
Mental retardation in mucopolysaccharidoses correlates with high molecular weight urinary heparan sulphate derived glucosamine. 329
Selective treatment to reduce contamination of propolis by polycyclic aromatic hydrocarbons (PAHs) still preserving its active polyphenol component and antioxidant activity 329
activity of chondroitin ABC lyase on dermatan sulfate partially degraded by cupric-ion-mediated free-radical treatment 327
Isolation, Purification and Structural Characterestics of Chondroitin Sulfate from Smooth hound Cartilage: In vitro Anticoagulant and Antiproliferative Properties 327
Separation of flavonoids and phenolic acids from propolis by capillary zone electrophoresis 322
Capillary electrophoresis separation of human milk neutral and acidic oligosaccharides derivatized with 2-aminoacridone. 319
Comparative analysis of fatty acid profile in three eutardigrade species 319
Electrophoretic approaches to the analysis of complex polysaccharides 315
Adsorption of glycosaminoglycans onto coral - a new possible implant biomaterials for regeneration therapy 313
Purification and characterization of heparin from the Italian clam Callista chione 312
Agarose-gel electrophoresis for the diagnosis of mucopolysaccharidoses 310
Analysis of glycosaminoglycan-derived, pre-column 2-aminoacridone-labeled disaccharides using liquid chromatography-fluorescence and -mass spectrometric detection. 308
effects of glycosaminoglycans on u-937 leukemia-cell proliferation and differentiation - structure-function relationship 306
Agarose-gel electrophoresis for the quality assurance and purity of heparin formulations 306
Atheroprotective remodelling of vascular dermatan sulphate proteoglycans in response to hypercholesterolaemia in a rat model 306
Therapeutic applications of glycosaminoglycans 306
Glycosaminoglycan Blotting and Detection After Electrophoresis Separation 305
Oral bioavailability of chondroitin sulfate (Condrosulf (R)) and its constituents in healthy male volunteers 304
Le arilsolfatasi come glicoconiugati: aspetti biochimico - comparati della loro regolazione 304
Purification, Structural Characterization and Antiproliferative Properties of Chondroitin Sulfate/Dermatan Sulfate from Tunisian Fish Skins 304
Chondroitin sulfate in normal human plasma is modified depending on the age. Its evaluation in patients with pseudoxanthoma elasticum 302
Composition and structure elucidation of human milk glycosaminoglycans 300
Recent advances on separation and characterization of human milk oligosaccharides. 300
Separation of keratan-sulfate-derived disaccharides by high-performance liquid chromatography and postcolumn derivatization with 2-cyanoacetamide and fluorimetric detection 296
Purification, compositional analysis, and anticoagulant capacity of chondroitin sulfate/dermatan sulfate from bone of corb (Sciaena umbra). 296
Shift of optimal pH in arylsulphatase from Mollusca depending on temperature 295
Improvement in the high-performance liquid chromatography malondialdehyde level determination in normal human plasma 294
The protein profile of fibroblasts: the role of proteomics. 293
Glycosaminoglycan content in term and preterm milk during the first month of lactation 291
Safety assessment of non-animal chondroitin sulfate sodium: Subchronic study in rats, genotoxicity tests and human bioavailability. 291
Composition of urinary glycosaminoglycans in a patient with pseudoxanthoma elasticum and familial Mediterranean fever 289
EFFECTS OF LOW-POWER 632 NM RADIATION (HENE LASER) ON A HUMAN CELL-LINE - INFLUENCE ON ADENYLNUCLEOTIDES AND CYTOSKELETAL STRUCTURES 287
Mild mental retardation and low levels of urinary heparan sulfate in a patient with the attenuated phenotype of Mucopolysaccharidosis type IIIA. 287
Purification and characterization of hyaluronic acid from the mollusc bivalve Mytilus galloprovincialis 286
Glycosaminoglycan composition of the large freshwater mollusc bivalve Anodonta anodonta 286
Fine characterization of mitral valve glycosaminoglycans and their modification with degenerative disease. 286
Isolation and structural characterization of chondroitin sulfate from bony fishes 286
Multi dynamic extraction: An innovative method to obtain a standardized chemically and biologically reproducible polyphenol extract from poplar-type propolis to be used for its anti-infective properties 285
High-performance capillary electrophoresis separation of hyaluronan oligosaccharides produced by Streptomyces hyalurolyticus hyaluronate lyase 284
Capillary electrophoresis of bacterial (lipo)polysaccharides 284
Effect of 6 years of enzyme replacement therapy on plasma and urine glycosaminoglycans in attenuated MPS I patients 282
Characterization of Oversulfated Chondroitin Sulfate Rich in 4,6-O-disulfated Disaccharides in Breast Cyst Fluids Collected from Human Breast Gross Cysts. 282
Determination of urinary hexosamines for diagnosis of bladder pain syndrome 281
Simultaneous detection of submicrogram quantities of hyaluronic acid and dermatan sulfate on agarose-gel by sequential staining with toluidine blue and Stains-All 279
1H and 13C Characterization of Chondroitin Sulphate from Porcine Trachea and Shark Cartilage 279
Capillary electrophoresis of complex natural polysaccharides 278
Electrophoresis for the analysis of heparin purity and quality. 277
Activity of chondroitin ABC lyase and hyaluronidase on free-radical degraded chondroitin sulfate 277
Human Milk Glycosaminoglycans Inhibit in vitro the Adhesion of Escherichia coli and Salmonella fyris to Human Intestinal Cells 276
Metabolic fate of milk glycosaminoglycans in breastfed and formula fed newborns. 273
Influence of charge density, sulfate group position and molecular mass on adsorption of chondroitin sulfate onto coral 272
Fine structural characterization of chondroitin sulfate in urine of bladder pain syndrome subjects 271
Recent advances in capillary electrophoresis separation of monosaccharides, oligosaccharides and polysaccharides 270
Quantitative and Qualitative Evaluation of ChondroitinSulfate in Dietary Supplements 268
Mass spectrometry characterization of Escherichia coli K4 oligosaccharides from 2-mers to more than 20-mers 267
1H and 13C Characterization of Chondroitin Sulphate from Beef Trachea 266
Human milk glycosaminoglycans: the state of the art and future perspectives 266
Anomalous structure of urinary glycosaminoglycans in patients with pseudoxanthoma elasticum 266
Direct and specific recognition of glycosaminoglycans by antibodies after their separation by agarose gel electrophoresis and blotting on cetylpyridinium chloride-treated nitrocellulose membranes 266
effect of low-frequency electromagnetic pulsed-field stimulation on yeast fermentation in presence of dicarboxylic and tricarboxylic acids 265
Characterization of a low-sulfated chondroitin sulfate isolated from the hemolymph of the freshwater snail Planorbarius corneus 263
Capillary electrophoresis of Biomolecules. Methods and Protocols. 259
Anti-zika virus and anti-usutu virus activity of human milk and its components 259
IMPLICANCIA DE LAS CADENAS DE GLICOSAMINOGLICANOS DE LA MATRIZ EXTRACELULAR EN LA “ATERO-RESISTENCIA” VASCULAR. 258
Role, metabolism, chemical modifications and applications of hyaluronan 257
Plasmatic kinetics of dermatan sulfate during enzyme replacement therapy with iduronate-2-sulfatase in a mucopolysaccharidosis II Patient 257
Analysis of normal levels of free glycosaminoglycans in urine and plasma in adults 257
Glycosaminoglycan levels and structure in a mucopolysaccharidosis IIIA mice and the effect of a highly secreted sulfamidase engineered to cross the blood-brain barrier 256
Physico-chemical properties and the structure of dermatan sulfate fractions purified from plasma after oral administration in healthy human volunteers 255
Isolation and characterization of a heparin with high anticoagulant activity from the clam Tapes phylippinarum: evidence for the presence of a high content of antithrombin III binding site 255
Quantitative capillary electrophoresis determination of oversulfated chondroitin sulfate as a contaminant in heparin preparations 255
Composition and structure of glycosaminoglycans in DBS from 2-3-day-old newborns for the diagnosis of mucopolysaccharidosis 255
Total and single species of uronic acid-bearing glycosaminoglycans in urine of newborns of 2-3 days of age for early diagnosis application 254
Totale 34.441
Categoria #
all - tutte 296.456
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 296.456


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021377 0 0 0 0 0 0 0 0 0 0 0 377
2021/20225.728 214 844 516 425 158 312 312 251 718 462 801 715
2022/20236.174 692 581 425 543 684 905 183 688 819 74 285 295
2023/20244.542 227 281 197 571 1.042 351 394 584 128 134 213 420
2024/202513.778 518 194 225 969 2.501 1.889 773 1.092 1.542 898 1.500 1.677
2025/202626.387 1.406 968 2.446 2.445 3.430 2.160 3.074 1.515 4.153 2.267 1.832 691
Totale 83.458